Speaker illustration

Doctor Matthew Li Kam Wa

Guy's and St Thomas' NHS Trust Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

The ARDVAARC study: real-world outcomes and the utility of bleeding risk scores in patients who require anticoagulation following percutaneous coronary intervention (PCI)

Event: ESC Congress 2018

Topic: Adjunctive Pharmacotherapy

Session: Risk scores at coronary revascularisation


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb